{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:05:23Z","timestamp":1787162723023,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,7,17]],"date-time":"2012-07-17T00:00:00Z","timestamp":1342483200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1038\/bjc.2012.315","type":"journal-article","created":{"date-parts":[[2012,7,17]],"date-time":"2012-07-17T16:03:13Z","timestamp":1342540993000},"page":"646-651","source":"Crossref","is-referenced-by-count":7,"title":["Effect of Paget\u2019s disease of bone (osteitis deformans) on the progression of prostate cancer bone metastasis"],"prefix":"10.1038","volume":"107","author":[{"given":"S-M","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Som","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C J","family":"Logothetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-H","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-CJ","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,17]]},"reference":[{"key":"BFbjc2012315_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ni1331","volume":"7","author":"GB Adams","year":"2006","unstructured":"Adams GB, Scadden DT (2006) The hematopoietic stem cell in its place [review]. Nat Immunol 7: 333\u2013337","journal-title":"Nat Immunol"},{"key":"BFbjc2012315_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Ales KA, Pompei P, MacKenzie CR (1987) A new method of classification of prognostic comorbidity for longitudinal studies: development and validation. J Chron Disease 40: 373\u2013383","journal-title":"J Chron Disease"},{"key":"BFbjc2012315_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00439-010-0888-2","volume":"128","author":"PYJ Chung","year":"2010","unstructured":"Chung PYJ, Beyens G, Boonen S, Papapoulos S, Geusens P, Karperien M, Vanhoenacker F, Verbruggen L, Fransen E, Van Offel J, Goemaere S, Zmierczak HG, Westhovens R, Devogelaer JP, Van Hul W (2010) The majority of the genetic risk for Paget\u2019s disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes. Hum Genet 128: 615\u2013626","journal-title":"Hum Genet"},{"key":"BFbjc2012315_CR4","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1001\/archinte.162.17.1985","volume":"162","author":"LX Clegg","year":"2002","unstructured":"Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK (2002) Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med 162: 1985\u20131993","journal-title":"Arch Intern Med"},{"key":"BFbjc2012315_CR5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1359\/jbmr.1999.14.2.192","volume":"14","author":"C Cooper","year":"1999","unstructured":"Cooper C, Schafheutle K, Dennison E, Kellingray S, Guyer P, Barker D (1999) The epidemiology of Paget\u2019s disease in Britain: is the prevalence decreasing? J Bone Miner Res 14: 192\u2013197","journal-title":"J Bone Miner Res"},{"key":"BFbjc2012315_CR6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/BF00054156","volume":"6","author":"KL Danley","year":"1995","unstructured":"Danley KL, Richardson JL, Bernstein L, Langholz B, Ross RK (1995) Prostate cancer: trends in mortality and stage-specific incidence rates by racial\/ethnic group in Los Angeles County, California (United States). Cancer Causes Control 6: 492\u2013498","journal-title":"Cancer Causes Control"},{"key":"BFbjc2012315_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nm1538","volume":"13","author":"D Diarra","year":"2007","unstructured":"Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heide D, Landewe R, Lacey D, Richards WG, Schett G (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13: 156\u2013163","journal-title":"Nat Med"},{"key":"BFbjc2012315_CR8","doi-asserted-by":"publisher","first-page":"7554","DOI":"10.1158\/0008-5472.CAN-05-1317","volume":"65","author":"CL Hall","year":"2005","unstructured":"Hall CL, Bafico A, Dai J, Aaronson SA, Keller ET (2005) Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Res 65: 7554\u20137560","journal-title":"Cancer Res"},{"key":"BFbjc2012315_CR9","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/pros.20805","volume":"68","author":"CL Hall","year":"2008","unstructured":"Hall CL, Daignault SD, Shah RB, Pienta KJ, Keller ET (2008) Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis. Prostate 68: 1396\u20131404","journal-title":"Prostate"},{"key":"BFbjc2012315_CR10","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1158\/0008-5472.CAN-10-4374","volume":"71","author":"Y-C Lee","year":"2011","unstructured":"Lee Y-C, Cheng C-J, Bilen MA, Lu JF, Satcher RL, Yu-Lee LY, Gallick GE, Maity SN, Lin SH (2011) BMP4 promotes prostate tumor growth in bone through osteogenesis. Cancer Res 71: 5194\u20135203","journal-title":"Cancer Res"},{"key":"BFbjc2012315_CR11","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.clinbiochem.2009.04.007","volume":"42","author":"MJ Marshall","year":"2009","unstructured":"Marshall MJ, Evans SF, Sharp CA, Powell DE, McCarthy HS, Davie MWJ (2009) Increased circulating Dickkopf-1 in Paget\u2019s disease of bone. Clin Biochem 42: 965\u2013969","journal-title":"Clin Biochem"},{"key":"BFbjc2012315_CR12","doi-asserted-by":"publisher","first-page":"e1002141","DOI":"10.1371\/journal.pcbi.1002141","volume":"7","author":"FS Roque","year":"2011","unstructured":"Roque FS, Jensen PB, Schmock H, Roque FS, Jensen PB, Schmock H, Dalgaard M, Andreatta M, Hansen T, S\u00f8eby K, Bredkj\u00e6r S, Juul A, Werge T, Jensen LJ, Brunak S (2011) Using electronic patient records to discover disease correlations and stratify patient cohorts. PLoS Comput Biol 7: e1002141","journal-title":"PLoS Comput Biol"},{"key":"BFbjc2012315_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0140-6736(11)61226-9","volume":"379","author":"MR Smith","year":"2012","unstructured":"Smith MR, Saad F, Coleman R, Shore N, Fizazi K, Tombal B, Miller K, Sieber P, Karsh L, Dami\u00e3o R, Tammela TL, Egerdie B, Van Poppel H, Chin J, Morote J, G\u00f3mez-Veiga F, Borkowski T, Ye Z, Kupic A, Dansey R, Goessl C (2012) Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial. Lancet 379: 39\u201346","journal-title":"Lancet"},{"key":"BFbjc2012315_CR14","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1056\/NEJMoa030847","volume":"349","author":"E Tian","year":"2003","unstructured":"Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD (2003) The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 349: 2483\u20132494","journal-title":"N Engl J Med"},{"key":"BFbjc2012315_CR15","first-page":"341","volume":"8","author":"S-M Tu","year":"2010","unstructured":"Tu S-M, Lin S-H, Podoloff DA, Logothetis CJ (2010) Multimodality therapy: bone-targeted radioisotope therapy of prostate cancer (review). Clin Adv Hematol Oncol 8: 341\u2013351","journal-title":"Clin Adv Hematol Oncol"},{"key":"BFbjc2012315_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/PPO.0b013e318161d32d","volume":"14","author":"S-M Tu","year":"2008","unstructured":"Tu S-M, Lin S-H (2008) Current trials using bone-targeting agents in prostate cancer (review). Cancer J 14: 35\u201339, ; erratum in Cancer J 2008 May-June; 14: 199","journal-title":"Cancer J"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2012315.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012315","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012315.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T09:09:21Z","timestamp":1684400961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2012315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,17]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["BFbjc2012315"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2012.315","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,17]]}}}